Cohen Matthew Gregory
Transaction: 06/15/2026
OTHER
Change
0
Price
Not reported
Filing
06/17/2026
Type
OTHER
Arrowhead Pharmaceuticals, Inc.
ARWR • Biotechnology
$86.34
▼ -0.15 (-0.17%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$12.24B
Growth
-0.8%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 46.9%Positive free cash flow · 1.17Manageable debt level · 0.79Healthy liquidity · 4.86Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:30 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$86.34
Change-0.17%
Market Cap$12.24B
52W Range15.01 - 95.49
Beta1.27
Gross Margin100.00%
Oper. Margin11.86%
Profit Margin-0.20%
Debt/Eq0.79
Current Ratio4.86
Quick Ratio4.86
Revenue 5Y-0.75%
Price$86.34
Change-0.17%
Market Cap$12.24B
52W Range15.01 - 95.49
Beta1.27
Gross Margin100.00%
Oper. Margin11.86%
Profit Margin-0.20%
Debt/Eq0.79
Current Ratio4.86
Quick Ratio4.86
Revenue 5Y-0.75%
FCF 5Y3.43%
Target$104.33
Target Upside20.84%
Target Median$115.00
Target Range46.00 - 126.00
Volume1.66M
Avg Volume2.19M
EPS Surprise0.25
Investment DNA
How strong this company looks for long-term investors
50
out of 100
Business Quality
Margins, moat, returns
33/100
Financial Strength
Debt, cash, stability
71/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
38/100
Why this score▼
Positive revenue growth · 46.9%Positive free cash flow · 1.17Manageable debt level · 0.79Healthy liquidity · 4.86Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$46.00
Mean
$104.33
Median
$115.00
High
$126.00
Insider Transactions
Recent executive and insider activity
Lu Hongbo
Transaction: 05/12/2026
SELL
Change
-2,970
Price
$76.88
Filing
05/14/2026
Type
SELL
Hamilton James C
Transaction: 04/23/2026
SELL
Change
-10,000
Price
$75.00
Filing
04/24/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Cohen Matthew Gregory | OTHER | 0 | Not reported | 06/15/2026 | 06/17/2026 |
| Lu Hongbo | SELL | -2,970 | $76.88 | 05/12/2026 | 05/14/2026 |
| Hamilton James C | SELL | -10,000 | $75.00 | 04/23/2026 | 04/24/2026 |
| Apel Daniel Joseph | SELL | -8,730 | $71.92 | 04/22/2026 | 04/24/2026 |
| Hamilton James C | SELL | -10,000 | $64.19 | 03/05/2026 | 03/09/2026 |
| O'Brien Patrick | SELL | -440 | Not reported | 01/06/2026 | 01/08/2026 |
| Apel Daniel Joseph | BUY | +75,000 | Not reported | 01/06/2026 | 01/08/2026 |
| Hamilton James C | BUY | +75,000 | Not reported | 01/06/2026 | 01/08/2026 |
| Hamilton James C | SELL | -309 | $68.00 | 01/05/2026 | 01/05/2026 |
| O'Brien Patrick | SELL | -46 | $68.00 | 01/05/2026 | 01/05/2026 |
| Anzalone Christopher Richard | SELL | -5,771 | $66.39 | 01/02/2026 | 01/05/2026 |
| O'Brien Patrick | SELL | -560 | Not reported | 12/31/2025 | 01/05/2026 |
| Anzalone Christopher Richard | SELL | -16,545 | $6.15 | 12/29/2025 | 12/30/2025 |
| Anzalone Christopher Richard | SELL | -16,545 | $68.69 | 12/29/2025 | 12/30/2025 |
| Ferrari Mauro | SELL | -7,530 | $70.00 | 12/26/2025 | 12/30/2025 |
| Anzalone Christopher Richard | SELL | -2,574 | $68.85 | 12/22/2025 | 12/23/2025 |
| OLUKOTUN ADEOYE Y | SELL | -827 | $68.48 | 12/19/2025 | 12/23/2025 |
| Anzalone Christopher Richard | SELL | -1,319 | $68.48 | 12/19/2025 | 12/23/2025 |
| Vakiener Victoria | SELL | -1,960 | $68.39 | 12/19/2025 | 12/23/2025 |
| Waddill William D. | SELL | -500 | $68.53 | 12/19/2025 | 12/23/2025 |